Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep - Chairman's EGM Address (ASX:IMM)

Ladies and Gentlemen, On behalf of the Board, I would like to welcome you to Immutep’s Extraordinary General Meeting to consider resolutions relating to the Company’s announced $60 mi...read more

Immutep - 2021 EGM Presentation (ASX:IMM)

To view the presentation, download the attached PDF.

Qualitas Real Estate Income Fund - Notification of Estimated Distribution (ASX:QRI)

QRI Manager Pty Ltd (“Manager”), the manager of the Qualitas Real Estate Income Fund (“QRI”), is pleased to declare a distribution for July 2021. The distribution for July 20...read more

Qualitas Real Estate Income Fund - Dividend/Distribution (ASX:QRI)

To view the Notification of dividend / distribution, download the attached PDF.

SUDA Pharmaceuticals - Quarterly Appendix 4C and Activities Report (ASX:SUD)

SUDA Pharmaceuticals Ltd (ASX: SUD), a biotechnology company focused on developing therapies to treat cancer and conditions that affect the central nervous system, today released its Appendix 4C for...read more

BARD1 Life Sciences - Updated Investor Presentation (ASX:BD1)

To view the presentation, download the attached PDF.

BARD1 Life Sciences - Terms of issue of Options (ASX:BD1)

Rights and liabilities attaching to the Options Unless otherwise defined, capitalised terms used below have the meaning given to those terms in the Appendix 3B announced to the market on 23 July ...read more

BARD1 Life Sciences - Investor Presentation (ASX:BD1)

To view the presentation, download the attached PDF.

BARD1 Life Sciences - Appendix 3B (ASX:BD1)

To view the Proposed issue of +securities, download the attached PDF.

BARD1 Life Sciences $15m Placement to Accelerate Cancer Diagnostic Program (ASX:BD1)

BARD1 completes $15 million placement with strong demand from new and existing institutional and sophisticated investors in Australia and Hong Kong Proceeds will be used primarily to fund develo...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the Notice of change of interests of substantial holder, download the attached PDF.

Immutep - Application for quotation of securities (ASX:IMM)

To view the Application for quotation of +securities, download the attached PDF.

Next Science - Record revenue growth in 1H 2021 (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) today announces its Quarterly Activity Report and Appendix 4C Quarterly Cash Flow Report for the period 1 April 2021 to 30 June 2021 (Q2). Highlights...read more

Next Science - Quarterly Activity Report - 30 June 2021 (ASX:NXS)

Judith Mitchell, Managing Director said: “In the first half of 2021, we delivered our best single half result since IPO. We reported 271% revenue growth (unaudited) on pcp (which was heavily p...read more